2,262 results on '"Freedland, Stephen J."'
Search Results
2. Relative search popularity of five advanced prostate cancer medications using Google Trends
3. Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer
4. Real-world overall survival with abiraterone acetate versus enzalutamide in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer
5. Concurrent prognostic utility of lymph node count and lymph node density for men with pathological node-positive prostate cancer
6. The effects of glycemic index on prostate cancer progression in a xenograft mouse model
7. Application of next-generation imaging in biochemically recurrent prostate cancer
8. Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification
9. Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare population
10. Prostate cancer in transgender women — challenges in research and clinical care
11. Genetic and biological drivers of prostate cancer disparities in Black men
12. Investigating trends in interest for benign prostatic hyperplasia surgery options using Google Trends
13. A US real-world study of treatment patterns and outcomes in localized or locally advanced prostate cancer patients
14. Validation of the prostate cancer comorbidity index in predicting cause-specific mortality in men undergoing radical prostatectomy
15. Correction: Application of next-generation imaging in biochemically recurrent prostate cancer
16. Can high-intensity interval training impact tumor suppression and inflammatory response in prostate cancer survivors?
17. Mechanisms governing lineage plasticity and metabolic reprogramming in cancer
18. Patient Perceptions of Standardized Risk Language Used in ACR Prostate MRI PI-RADS Scores
19. Are associations between obesity and prostate cancer outcomes following radical prostatectomy the same in smokers and non-smokers? Results from the SEARCH Cohort
20. Healthcare Costs in Men with Metastatic Castration-Resistant Prostate Cancer: An Analysis of US Medicare Fee-For-Service Claims
21. The impact of race on survival in metastatic prostate cancer: a systematic literature review
22. Prostate-specific antigen response and clinical progression-free survival in Black and White men with chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide in a real-world setting
23. Treatment Intensification With Novel Hormonal Therapy in Castration-Sensitive Prostate Cancer: Patient Identification and Clinical Rationale
24. Applications of wearable activity monitors for prostate cancer survivors: A systematic scoping review
25. Fatigue Management in Advanced Prostate Cancer: Real-World Insights From Qualitative Interviews With Patients
26. Dietary Fiber Intake and Risk of Advanced and Aggressive Forms of Prostate Cancer: A Pooled Analysis of 15 Prospective Cohort Studies
27. A healthy diet, a healthy prostate? A brief commentary on the latest research on diet and prostate cancer
28. Working hard or hardly working? A brief commentary of latest research on exercise and prostate cancer
29. Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)?
30. Real-world evidence of patients with metastatic castration-resistant prostate cancer treated with cabazitaxel: comparison with the randomized clinical study CARD
31. Metabolic syndrome is associated with aggressive prostate cancer regardless of race
32. A Proposal for the Comprehensive Care of Men on Androgen Deprivation Therapy: Recommendations From the Multidisciplinary Prostate Cancer 360 Working Group
33. Reply by Authors
34. Plant-based diets to reduce prostate cancer risk and improve prostate cancer outcomes—ready for prime time?
35. Survival and Economic Impact of Rapid Prostate-Specific Antigen Doubling Time in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
36. Survival by race in men with chemotherapy-naive enzalutamide- or abiraterone-treated metastatic castration-resistant prostate cancer
37. The 17-Gene Genomic Prostate Score Test Is Prognostic for Outcomes After Primary External Beam Radiation Therapy in Men With Clinically Localized Prostate Cancer
38. Prostate-Specific Antigen Screening in Transgender Patients
39. Variation in content discussed by specialty in consultations for clinically localized prostate cancer
40. Race reporting and disparities regarding clinical trials in bladder cancer: a systematic review
41. Lifestyle and sociodemographic factors associated with treatment choice of clinically localized prostate cancer in an equal access healthcare system
42. Contemporary risk of biochemical recurrence after radical prostatectomy in the active surveillance era
43. Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort
44. Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race
45. Statins and prostate cancer—hype or hope? The epidemiological perspective
46. Statins and prostate cancer—hype or hope? The biological perspective
47. Serum metabolomic analysis of men on a low-carbohydrate diet for biochemically recurrent prostate cancer reveals the potential role of ketogenesis to slow tumor growth: a secondary analysis of the CAPS2 diet trial
48. Geographic distribution of racial differences in mortality in muscle-invasive bladder cancer patients: an opportunity for improvement
49. First-line Immune Checkpoint Inhibitor Combinations in Metastatic Renal Cell Carcinoma: Where Are We Going, Where Have We Been?
50. Accommodating heterogeneous missing data patterns for prostate cancer risk prediction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.